Functional status in older patients with lung cancer: an observational cohort study
Purpose An assessment of the impact of functional status (FS) evaluated using a combination of Activities of Daily Living (ADL) and the short version of the Instrumental Activities of Daily Living (IADL), on 3- and 6- month mortality and on 3-month unplanned hospitalizations in older patients treated for lung cancers. Method and objectives This observational retrospective study was conducted between September 2015 and January 2019 at Marseille University Hospital (AP-HM). During this period, all consecutive outpatients aged 70 years or older referred for a comprehensive geriatric assessment (CGA) before the initiation of lung cancer treatment were enrolled. Results Two hundred twenty-seven patients were analyzed: the median age was 78.7 years and 74.0% were male. Almost half of the patients were metastatic (45.4%). Concerning FS, 41.9% of patients had no ADL-IADL impairment, 30.0% had either IADL or ADL impairment, and both ADL-IADL were impaired for 28.1%. Impaired ADL-IADL was associated with poor nutritional status, depression, mobility, and cognitive disorders. In a logistic regression model, ADL or IADL impairment (aOR = 2.1; 95% CI [1.0–4.2]; p = 0.037) and impaired ADL-IADL (aOR = 2.6; 95% CI [1.2–5.3]; p = 0.012) were independently associated with a higher risk of unplanned hospitalizations within 3 months. In the multivariate Cox model, 6-month mortality risk was independently associated with impaired ADL-IADL (aHR = 2.3; 95% CI [1.3–4.4]; p = 0.008). Conclusion The combination of ADL and IADL scales to assess FS is a prognostic marker of the mortality risk at 6 months in older patients with lung cancer and should be more largely used by oncologists in treatment decision making..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:30 |
---|---|
Enthalten in: |
Supportive care in cancer - 30(2022), 5 vom: 15. Jan., Seite 3817-3827 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Couderc, Anne-Laure [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
Themen: |
Aged |
---|
Anmerkungen: |
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 |
---|
doi: |
10.1007/s00520-021-06752-2 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC2078325295 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | OLC2078325295 | ||
003 | DE-627 | ||
005 | 20230509190713.0 | ||
007 | tu | ||
008 | 221220s2022 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1007/s00520-021-06752-2 |2 doi | |
035 | |a (DE-627)OLC2078325295 | ||
035 | |a (DE-He213)s00520-021-06752-2-p | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
100 | 1 | |a Couderc, Anne-Laure |e verfasserin |0 (orcid)0000-0003-2938-2201 |4 aut | |
245 | 1 | 0 | |a Functional status in older patients with lung cancer: an observational cohort study |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 | ||
520 | |a Purpose An assessment of the impact of functional status (FS) evaluated using a combination of Activities of Daily Living (ADL) and the short version of the Instrumental Activities of Daily Living (IADL), on 3- and 6- month mortality and on 3-month unplanned hospitalizations in older patients treated for lung cancers. Method and objectives This observational retrospective study was conducted between September 2015 and January 2019 at Marseille University Hospital (AP-HM). During this period, all consecutive outpatients aged 70 years or older referred for a comprehensive geriatric assessment (CGA) before the initiation of lung cancer treatment were enrolled. Results Two hundred twenty-seven patients were analyzed: the median age was 78.7 years and 74.0% were male. Almost half of the patients were metastatic (45.4%). Concerning FS, 41.9% of patients had no ADL-IADL impairment, 30.0% had either IADL or ADL impairment, and both ADL-IADL were impaired for 28.1%. Impaired ADL-IADL was associated with poor nutritional status, depression, mobility, and cognitive disorders. In a logistic regression model, ADL or IADL impairment (aOR = 2.1; 95% CI [1.0–4.2]; p = 0.037) and impaired ADL-IADL (aOR = 2.6; 95% CI [1.2–5.3]; p = 0.012) were independently associated with a higher risk of unplanned hospitalizations within 3 months. In the multivariate Cox model, 6-month mortality risk was independently associated with impaired ADL-IADL (aHR = 2.3; 95% CI [1.3–4.4]; p = 0.008). Conclusion The combination of ADL and IADL scales to assess FS is a prognostic marker of the mortality risk at 6 months in older patients with lung cancer and should be more largely used by oncologists in treatment decision making. | ||
650 | 4 | |a Functional status | |
650 | 4 | |a Daily living activities | |
650 | 4 | |a Lung cancer | |
650 | 4 | |a Aged | |
650 | 4 | |a Mortality | |
650 | 4 | |a Cancer treatment protocols | |
700 | 1 | |a Tomasini, Pascale |4 aut | |
700 | 1 | |a Greillier, Laurent |4 aut | |
700 | 1 | |a Nouguerède, Emilie |4 aut | |
700 | 1 | |a Rey, Dominique |4 aut | |
700 | 1 | |a Montegut, Coline |4 aut | |
700 | 1 | |a Thomas, Pascal-Alexandre |4 aut | |
700 | 1 | |a Barlesi, Fabrice |4 aut | |
700 | 1 | |a Villani, Patrick |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Supportive care in cancer |d Springer Berlin Heidelberg, 1993 |g 30(2022), 5 vom: 15. Jan., Seite 3817-3827 |w (DE-627)170972038 |w (DE-600)1134446-5 |w (DE-576)032868545 |x 0941-4355 |7 nnns |
773 | 1 | 8 | |g volume:30 |g year:2022 |g number:5 |g day:15 |g month:01 |g pages:3817-3827 |
856 | 4 | 1 | |u https://doi.org/10.1007/s00520-021-06752-2 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a GBV_ILN_2018 | ||
912 | |a GBV_ILN_4277 | ||
951 | |a AR | ||
952 | |d 30 |j 2022 |e 5 |b 15 |c 01 |h 3817-3827 |